As our Daily News team reports, the US Food and Drug Administration is creating a new position to focus on genomics-related programs. Liz Mansfield, who has worked on science policy in the past, will fill the new post. Over at Science Progress, Michael Rugnetta says, "The position is significant because it heralds the FDA's focus on developing approaches to personalized medicine." However, Rugnetta later adds that the US healthcare system is a long ways away from incorporating personalized medicine into everyday clinical care. Two initiatives that he says are needed to see that day are the "adoption of digital health records and a reformed reimbursement process that rewards positive clinical outcomes instead of just additional procedures and tests."
Getting Personal: Feb 10, 2009
Feb 10, 2009